US Stock MarketDetailed Quotes

Iovance Biotherapeutics (IOVA)

Watchlist

3.560
-0.100-2.73%

Trading May 14 10:13 ET

1.59BMarket Cap-3.87P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Iovance Biotherapeutics (IOVA) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2026

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

30.49%-72.07M

14.33%-302.41M

28.28%-52.57M

-33.45%-78.7M

31.48%-67.45M

15.20%-103.69M

2.44%-352.98M

12.71%-73.3M

29.86%-58.97M

-4.77%-98.43M

Net income from continuing operations

31.95%-79.05M

-5.05%-390.98M

8.47%-71.9M

-9.23%-91.25M

-14.99%-111.66M

-2.82%-116.16M

16.18%-372.18M

32.50%-78.56M

26.56%-83.54M

8.85%-97.1M

Operating gains losses

348.54%462K

-112.03%-194K

-120.83%-373K

349.46%232K

-1,660.00%-156K

207.29%103K

2,202.86%1.61M

1,789.62%1.79M

-126.05%-93K

--10K

Depreciation and amortization

-4.76%10.42M

-1.55%47.32M

-26.33%12.64M

15.20%11.68M

11.08%12.07M

10.38%10.94M

45.11%48.07M

76.69%17.16M

2.64%10.14M

38.55%10.86M

Deferred tax

63.82%-665K

26.77%-2.07M

-88.20%184K

-58.12%-2.41M

236.35%1.99M

-30.54%-1.84M

18.71%-2.83M

188.63%1.56M

-22.37%-1.52M

-205.66%-1.46M

Change In working capital

26.35%-12.88M

80.90%-24.27M

83.22%-7.29M

30.65%-8.53M

123.39%9.05M

46.25%-17.49M

-1,847.88%-127.02M

-465.55%-43.46M

-308.91%-12.31M

-237.50%-38.71M

-Change in receivables

143.18%690K

81.05%-13.11M

-15.58%-15.69M

71.76%-6.82M

135.07%11M

-1,825.30%-1.6M

-46,335.57%-69.19M

-9,008.72%-13.57M

-73,324.24%-24.16M

-94,960.61%-31.37M

-Change in inventory

64.36%-4.93M

67.98%-14.21M

78.86%-4M

67.73%-3.18M

176.83%6.81M

-105.40%-13.83M

-338.64%-44.38M

-1,950.60%-18.93M

-2,885.59%-9.86M

7.23%-8.86M

-Change in prepaid assets

54.91%-1.47M

-279.70%-8.02M

87.57%-661K

212.30%2.78M

-3,163.98%-6.89M

-155.21%-3.25M

79.00%-2.11M

-3.30%-5.32M

-214.92%-2.47M

92.55%-211K

-Change in payables and accrued expense

-219.71%-5.15M

2,881.82%21.98M

902.62%15.96M

-95.92%1.11M

-86.15%612K

114.92%4.3M

-97.00%737K

-109.54%-1.99M

340.18%27.14M

21.44%4.42M

-Change in other current liabilities

34.89%-2.03M

9.72%-10.9M

20.57%-2.9M

18.17%-2.41M

7.88%-2.48M

-11.62%-3.11M

-11.86%-12.07M

-34.23%-3.65M

-4.69%-2.95M

0.11%-2.69M

Cash from discontinued investing activities

Operating cash flow

30.49%-72.07M

14.33%-302.41M

28.28%-52.57M

-33.45%-78.7M

31.48%-67.45M

15.20%-103.69M

2.44%-352.98M

12.71%-73.3M

29.86%-58.97M

-4.77%-98.43M

Investing cash flow

Cash flow from continuing investing activities

-28.19%11.39M

149.26%47.5M

-96.73%775K

134.86%17.01M

-65.58%13.84M

114.23%15.87M

37.90%-96.41M

132.50%23.68M

38.24%-48.8M

125.65%40.22M

Net PPE purchase and sale

-6.39%-6.61M

-205.68%-33.84M

-123.61%-9.32M

-373.95%-10.84M

-1,588.01%-7.46M

-48.91%-6.21M

50.34%-11.07M

-18.11%-4.17M

36.04%-2.29M

95.36%-442K

Net business purchase and sale

----

--0

75.28%-52.57M

--0

Net investment purchase and sale

-18.46%18M

348.20%81.33M

-63.75%10.1M

159.89%27.86M

-47.61%21.3M

140.32%22.08M

-141.13%-32.77M

140.03%27.85M

35.45%-46.51M

-34.68%40.66M

Cash from discontinued investing activities

Investing cash flow

-28.19%11.39M

149.26%47.5M

-96.73%775K

134.86%17.01M

-65.58%13.84M

114.23%15.87M

37.90%-96.41M

132.50%23.68M

38.24%-48.8M

125.65%40.22M

Financing cash flow

Cash flow from continuing financing activities

-34.18%94.34M

-23.01%300.77M

2,332.74%56.17M

109.89%88.06M

-91.34%13.23M

-25.96%143.32M

-15.62%390.66M

140.02%2.31M

-79.31%41.95M

14,809.76%152.83M

Net common stock issuance

-33.86%98.51M

-22.90%306.31M

--55.78M

86.29%88.52M

-91.40%13.07M

-24.74%148.94M

-14.24%397.3M

--0

-76.61%47.52M

--151.87M

Proceeds from stock option exercised by employees

--0

-75.47%1.53M

-73.69%839K

-99.72%2K

-65.73%669K

-95.88%15K

151.44%6.22M

178.03%3.19M

--713K

47.21%1.95M

Net other financing activities

25.96%-4.18M

45.10%-7.06M

49.43%-445K

92.58%-466K

49.60%-504K

-20.06%-5.64M

-360.04%-12.86M

-373.12%-880K

-1,556.20%-6.28M

-232.23%-1M

Cash from discontinued financing activities

Financing cash flow

-34.18%94.34M

-23.01%300.77M

2,332.74%56.17M

109.89%88.06M

-91.34%13.23M

-25.96%143.32M

-15.62%390.66M

140.02%2.31M

-79.31%41.95M

14,809.76%152.83M

Net cash flow

Beginning cash position

38.51%169.06M

-32.69%122.05M

-3.78%164.1M

-41.13%138.41M

26.62%178.05M

-32.69%122.05M

-23.87%181.32M

-48.96%170.54M

-20.69%235.11M

-74.43%140.62M

Current changes in cash

-39.35%33.66M

178.10%45.86M

109.26%4.38M

140.06%26.37M

-142.67%-40.38M

238.00%55.49M

-8.54%-58.72M

69.64%-47.31M

-265.78%-65.82M

137.89%94.62M

Effect of exchange rate changes

-141.93%-213K

311.46%1.14M

148.98%577K

-154.27%-680K

691.20%739K

203.46%508K

80.26%-541K

-138.99%-1.18M

162.87%1.25M

96.68%-125K

End cash Position

13.73%202.5M

38.51%169.06M

-3.78%164.1M

-41.13%138.41M

26.62%178.05M

-32.69%122.05M

-48.96%170.54M

-20.69%235.11M

Free cash flow

28.41%-78.68M

7.64%-336.24M

20.11%-61.89M

-46.17%-89.55M

24.24%-74.91M

13.08%-109.91M

5.22%-364.05M

11.47%-77.46M

30.12%-61.26M

4.45%-98.87M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2026	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	30.49%-72.07M	14.33%-302.41M	28.28%-52.57M	-33.45%-78.7M	31.48%-67.45M	15.20%-103.69M	2.44%-352.98M	12.71%-73.3M	29.86%-58.97M	-4.77%-98.43M
Net income from continuing operations	31.95%-79.05M	-5.05%-390.98M	8.47%-71.9M	-9.23%-91.25M	-14.99%-111.66M	-2.82%-116.16M	16.18%-372.18M	32.50%-78.56M	26.56%-83.54M	8.85%-97.1M
Operating gains losses	348.54%462K	-112.03%-194K	-120.83%-373K	349.46%232K	-1,660.00%-156K	207.29%103K	2,202.86%1.61M	1,789.62%1.79M	-126.05%-93K	--10K
Depreciation and amortization	-4.76%10.42M	-1.55%47.32M	-26.33%12.64M	15.20%11.68M	11.08%12.07M	10.38%10.94M	45.11%48.07M	76.69%17.16M	2.64%10.14M	38.55%10.86M
Deferred tax	63.82%-665K	26.77%-2.07M	-88.20%184K	-58.12%-2.41M	236.35%1.99M	-30.54%-1.84M	18.71%-2.83M	188.63%1.56M	-22.37%-1.52M	-205.66%-1.46M
Change In working capital	26.35%-12.88M	80.90%-24.27M	83.22%-7.29M	30.65%-8.53M	123.39%9.05M	46.25%-17.49M	-1,847.88%-127.02M	-465.55%-43.46M	-308.91%-12.31M	-237.50%-38.71M
-Change in receivables	143.18%690K	81.05%-13.11M	-15.58%-15.69M	71.76%-6.82M	135.07%11M	-1,825.30%-1.6M	-46,335.57%-69.19M	-9,008.72%-13.57M	-73,324.24%-24.16M	-94,960.61%-31.37M
-Change in inventory	64.36%-4.93M	67.98%-14.21M	78.86%-4M	67.73%-3.18M	176.83%6.81M	-105.40%-13.83M	-338.64%-44.38M	-1,950.60%-18.93M	-2,885.59%-9.86M	7.23%-8.86M
-Change in prepaid assets	54.91%-1.47M	-279.70%-8.02M	87.57%-661K	212.30%2.78M	-3,163.98%-6.89M	-155.21%-3.25M	79.00%-2.11M	-3.30%-5.32M	-214.92%-2.47M	92.55%-211K
-Change in payables and accrued expense	-219.71%-5.15M	2,881.82%21.98M	902.62%15.96M	-95.92%1.11M	-86.15%612K	114.92%4.3M	-97.00%737K	-109.54%-1.99M	340.18%27.14M	21.44%4.42M
-Change in other current liabilities	34.89%-2.03M	9.72%-10.9M	20.57%-2.9M	18.17%-2.41M	7.88%-2.48M	-11.62%-3.11M	-11.86%-12.07M	-34.23%-3.65M	-4.69%-2.95M	0.11%-2.69M
Cash from discontinued investing activities
Operating cash flow	30.49%-72.07M	14.33%-302.41M	28.28%-52.57M	-33.45%-78.7M	31.48%-67.45M	15.20%-103.69M	2.44%-352.98M	12.71%-73.3M	29.86%-58.97M	-4.77%-98.43M
Investing cash flow
Cash flow from continuing investing activities	-28.19%11.39M	149.26%47.5M	-96.73%775K	134.86%17.01M	-65.58%13.84M	114.23%15.87M	37.90%-96.41M	132.50%23.68M	38.24%-48.8M	125.65%40.22M
Net PPE purchase and sale	-6.39%-6.61M	-205.68%-33.84M	-123.61%-9.32M	-373.95%-10.84M	-1,588.01%-7.46M	-48.91%-6.21M	50.34%-11.07M	-18.11%-4.17M	36.04%-2.29M	95.36%-442K
Net business purchase and sale	----	--0	--0	--0	--0	--0	75.28%-52.57M	--0	--0	--0
Net investment purchase and sale	-18.46%18M	348.20%81.33M	-63.75%10.1M	159.89%27.86M	-47.61%21.3M	140.32%22.08M	-141.13%-32.77M	140.03%27.85M	35.45%-46.51M	-34.68%40.66M
Cash from discontinued investing activities
Investing cash flow	-28.19%11.39M	149.26%47.5M	-96.73%775K	134.86%17.01M	-65.58%13.84M	114.23%15.87M	37.90%-96.41M	132.50%23.68M	38.24%-48.8M	125.65%40.22M
Financing cash flow
Cash flow from continuing financing activities	-34.18%94.34M	-23.01%300.77M	2,332.74%56.17M	109.89%88.06M	-91.34%13.23M	-25.96%143.32M	-15.62%390.66M	140.02%2.31M	-79.31%41.95M	14,809.76%152.83M
Net common stock issuance	-33.86%98.51M	-22.90%306.31M	--55.78M	86.29%88.52M	-91.40%13.07M	-24.74%148.94M	-14.24%397.3M	--0	-76.61%47.52M	--151.87M
Proceeds from stock option exercised by employees	--0	-75.47%1.53M	-73.69%839K	-99.72%2K	-65.73%669K	-95.88%15K	151.44%6.22M	178.03%3.19M	--713K	47.21%1.95M
Net other financing activities	25.96%-4.18M	45.10%-7.06M	49.43%-445K	92.58%-466K	49.60%-504K	-20.06%-5.64M	-360.04%-12.86M	-373.12%-880K	-1,556.20%-6.28M	-232.23%-1M
Cash from discontinued financing activities
Financing cash flow	-34.18%94.34M	-23.01%300.77M	2,332.74%56.17M	109.89%88.06M	-91.34%13.23M	-25.96%143.32M	-15.62%390.66M	140.02%2.31M	-79.31%41.95M	14,809.76%152.83M
Net cash flow
Beginning cash position	38.51%169.06M	-32.69%122.05M	-3.78%164.1M	-41.13%138.41M	26.62%178.05M	-32.69%122.05M	-23.87%181.32M	-48.96%170.54M	-20.69%235.11M	-74.43%140.62M
Current changes in cash	-39.35%33.66M	178.10%45.86M	109.26%4.38M	140.06%26.37M	-142.67%-40.38M	238.00%55.49M	-8.54%-58.72M	69.64%-47.31M	-265.78%-65.82M	137.89%94.62M
Effect of exchange rate changes	-141.93%-213K	311.46%1.14M	148.98%577K	-154.27%-680K	691.20%739K	203.46%508K	80.26%-541K	-138.99%-1.18M	162.87%1.25M	96.68%-125K
End cash Position	13.73%202.5M	38.51%169.06M	38.51%169.06M	-3.78%164.1M	-41.13%138.41M	26.62%178.05M	-32.69%122.05M	-32.69%122.05M	-48.96%170.54M	-20.69%235.11M
Free cash flow	28.41%-78.68M	7.64%-336.24M	20.11%-61.89M	-46.17%-89.55M	24.24%-74.91M	13.08%-109.91M	5.22%-364.05M	11.47%-77.46M	30.12%-61.26M	4.45%-98.87M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm